Foto del docente

Arrigo Francesco Giuseppe Cicero

Professore associato

Dipartimento di Scienze Mediche e Chirurgiche

Settore scientifico disciplinare: MED/49 SCIENZE TECNICHE DIETETICHE APPLICATE

Pubblicazioni

Russo E, Viazzi F, Pontremoli R, Barbagallo CM, Bombelli M, Casiglia E, Cicero AFG, Cirillo M, Cirillo P, Desideri G, D'Elia L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Leoncini G, Mallamaci F, Maloberti A, Masi S, Mengozzi A, Mazza A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Rattazzi M, Rivasi G, Salvetti M, Tikhonoff V, Tocci G, Ungar A, Verdecchia P, Virdis A, Volpe M, Grassi G, Borghi C, Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension, Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project, «JN. JOURNAL OF NEPHROLOGY», 2022, 35, pp. 211 - 221 [articolo]

Fogacci F, Rizzoli E, Giovannini M, Bove M, D'Addato S, Borghi C, Cicero AFG, Effect of Dietary Supplementation with Eufortyn® Colesterolo Plus on Serum Lipids, Endothelial Reactivity, Indexes of Non-Alcoholic Fatty Liver Disease and Systemic Inflammation in Healthy Subjects with Polygenic Hypercholesterolemia: The ANEMONE Study. Nutrients. 2022 May 18;14(10):209, «NUTRIENTS», 2022, 14, pp. 1 - 11 [articolo]

Borghi C, Fogacci F, Agnoletti D, Cicero AFG, Hypertension and Dyslipidemia Combined Therapeutic Approaches, «HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION», 2022, 29, pp. 221 - 230 [articolo]

Borghi C, Fogacci F, Agnoletti D, Cicero AFG., Hypertension and Dyslipidemia Combined Therapeutic Approaches., «HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION», 2022, 29, pp. 221 - 230 [articolo]

Cicero A.F.G.; Fogacci F.; Rizzoli E.; Giovannini M.; D'Addato S.; Borghi C.; Grandi E.; Ventura F.; Coppola P.; Ianniello E.; Soldati M.; Piani F.; Iamino I.R.; Palmisano S.; Landolfo M.; Bacchelli S., Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up, «NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES», 2022, 32, pp. 2246 - 2254 [articolo]

Banerjee Y, Pantea Stoian A, Cicero AFG, Fogacci F, Nikolic D, Sachinidis A, Rizvi AA, Janez A, Rizzo M, Inclisiran: a small interfering RNA strategy targeting PCSK9 to treat hypercholesterolemia, «EXPERT OPINION ON DRUG SAFETY», 2022, 21, pp. 9 - 20 [articolo]

Cicero AFG, Fogacci F, Derosa G, D'Angelo A, Ventura F, Rizzoli E, D'Addato S, Borghi C, On Behalf Of The Brisighella Heart Study Group, Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study, «BIOMEDICINES», 2022, 10, pp. 1 - 11 [articolo]

Imbalzano E, Orlando L, Sciacqua A, Nato G, Dentali F, Nassisi V, Russo V, Camporese G, Bagnato G, Cicero AFG, Dattilo G, Vatrano M, Versace AG, Squadrito G, Di Micco P, Machine Learning to Calculate Heparin Dose in COVID-19 Patients with Active Cancer, «JOURNAL OF CLINICAL MEDICINE», 2022, 11, Article number: 219, pp. 1 - 13 [articolo]Open Access

Fogacci F, Giovannini M, Grandi E, Imbalzano E, Degli Esposti D, Borghi C, Cicero AFG, Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients., «JOURNAL OF CLINICAL MEDICINE», 2022, 11, pp. 1 - 11 [articolo]

Fogacci F, Borghi C, Cicero AFG, New evidences on the association between high-density lipoprotein cholesterol and cardiovascular risk: a never ending research story, «EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY», 2022, 29, pp. 842 - 843 [articolo]

Cicero AFG, Fogacci F, Di Micoli A, Veronesi M, Borghi C, Noninvasive instrumental evaluation of coenzyme Q10 phytosome on endothelial reactivity in healthy nonsmoking young volunteers: A double-blind, randomized, placebo-controlled crossover clinical trial, «BIOFACTORS», 2022, 48, pp. 1160 - 1165 [articolo]

Fogacci F, Borghi C, Grassi D, Cicero AFG, People living with human immunodeficiency virus: Cardiovascular risk screening for an early and effective risk management., «ATHEROSCLEROSIS», 2022, 353, pp. 28 - 29 [articolo]

GiorgiaPagnotta, Susheel Kalia, Luana Di Lisa, Arrigo F.G.Cicero, ClaudioBorghi, Maria LetiziaFocarete, Progress towards 3D bioprinting of tissue models for advanced drug screening: In vitro evaluation of drug toxicity and drug metabolism, «BIOPRINTING», 2022, 27, pp. 1 - 16 [articolo]

Pagnotta G.; Kalia S.; Di Lisa L.; Cicero A.F.G.; Borghi C.; Focarete M.L., Progress towards 3D bioprinting of tissue models for advanced drug screening: In vitro evaluation of drug toxicity and drug metabolism, «BIOPRINTING», 2022, 27, Article number: e00218, pp. 1 - 16 [articolo]

Enayati A, Banach M, Jamialahmadi T, Sahebkar A; endorsed by the International Lipid Expert Panel (ILEP) , Cicero AFG, Protective role of nutraceuticals against myocarditis, «BIOMÉDECINE & PHARMACOTHÉRAPIE», 2022, 146, pp. 1 - 11 [articolo]Open Access

Ultimi avvisi

Al momento non sono presenti avvisi.